Amarantus BioScience Holdings Inc. is a biotechnology company discovering and developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis, such as retinitis pigmentosa, Parkinson's disease, Alzheimer's disease, traumatic brain injury and other human diseases.